C4 Therapeutics Inc is trading at $3.61 (down 6.3%) as the stock extends a multi-session pullback following a strong rally in late May and early June.
- Recent commentary highlights profit-taking and the stock’s high volatility and high beta profile, which can amplify downside moves even as broader indices trade higher.
- No new company-specific news or rating changes emerged this morning to explain the additional decline.